Drug Repositioning: Current Advances and Future Perspectives
Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...
Saved in:
Main Author: | Yuhei Nishimura (auth) |
---|---|
Other Authors: | Hideaki Hara (auth) |
Format: | Book Chapter |
Published: |
Frontiers Media SA
2019
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Published: (2021) -
Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design
Published: (2019) -
Molecular Modeling in Drug Design
by: Wade, Rebecca
Published: (2019) -
Advances and New Perspectives in Marine Biotechnology : Marine Microbes & Metagenomes
by: Paul Long (Ed.)
Published: (2015) -
Advances and New Perspectives in Marine Biotechnology : Marine Animals & Plants
by: Paul Long (Ed.)
Published: (2015)